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exposure and, over a period of days and especially under a
high O2 gas atmosphere, gradual appearance of cell types
carrying markers for more differentiated TB cell types,
including extravillous TB and syncytioTB. We describe
the potential value of including low molecular weight phar-
maceutical agents that block activin A (INHBA) and FGF2
signaling to support BMP4-directed differentiation. We con-
tend that the weight of available evidence supports the
contention that BMP4 converts human ESC and iPSC of
the so-called epiblast type unidirectionally to TB. We also
consider the argument that BMP4 treatment of human ESC
Introduction
A placenta originating from the outer cells (trophectoderm)
of the early blastocyst is the hallmark of mammals. In
eutherians, unlike the marsupials, whose placenta is short-
lived, the fetus is nurtured in utero for an extended period of
time and the placenta becomes well developed and involved
in a multitude of processes essential to maintain the preg-
nancy until the offspring are born. These functions include
transport of nutrients, exchange of gases, production of both
steroid and polypeptide hormones, structural support within
the womb, immunological protection and acting as a phys-
iological buffer between the mother and the fetus; yet,
despite these commonalities, the placenta is arguably the
most diverse of mammalian organs, showing bewildering
variation in organization and gross morphology (Enders and
Blankenship 1999; Enders and Carter 2006). For example,
within the primate order, placental types range from those
that are highly invasive, as seen in the human, to those in
which the placental trophoblast (TB) fails to penetrate the
uterine epithelium at all, as in pro-simians (King 1992). This
structural heterogeneity presumably reflects evolutionary
adaptation to the on-going conflict over control of available
T. Ezashi : R. M. Roberts
Division of Animal Sciences & Bond Life Sciences Center,
University of Missouri-Columbia,
Columbia, MO 65211, USA
B. P. V. L. Telugu
Department of Animal and Avian Sciences, College Park,
MD 20742 & Animal Biosciences and Biotechnology Laboratory,
ANRI, ARS, USDA, University of Maryland,
Beltsville, MD 20705, USA
R. M. Roberts (*)
240b Bond Life Sciences Center,
1201 E. Rollins Street,
Columbia, MO 65211-7310, USA
e-mail: robertsrm@missouri.edu
Cell Tissue Res (2012) 349:809–824
DOI 10.1007/s00441-012-1371-2
# The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract This review focuses on a now well-established
model for generating cells of the trophoblast (TB) lineage by
treating human embryonic stem cells (ESC) and induced
pluripotent stem cells (iPSC) with the growth factor
BMP4. We first discuss the opposing roles of FGF2 and
BMP4 in directing TB formation and the need to exclude the
former from the growth medium to minimize the co-
induction of mesoderm and endoderm. Under these condi-
tions, there is up-regulation of several transcription factors
implicated in TB lineage emergence within 3 h of BMP4
in the absence of exogenous FGF2 leads only to the emer-
gence of mesoderm derivatives to be seriously flawed. In-
stead, we propose that, when signaling networks supporting
pluripotency ESC or iPSC become unsustainable and when
specification towards extra-embryonic mesoderm and endo-
derm are rendered inoperative, TB emerges as a major
default state to pluripotency.
Keywords Pluripotent . Embryonic stem cell . Placenta .
Trophoblast differentiation . BMP4
nutrient resources, which the mother supplies and the fetus
exploits and also the on-going challenge to fetal survival in
the face of a potentially hostile and capricious maternal
immune system.
The human placenta is morphologically complex (Fig. 1)
but does bear some resemblance to that of the mouse
(Pijnenborg et al. 1981; Aubuchon et al. 2011). It is
discoid in shape, possesses a multinucleated syncytium
in association with its absorptive interface and is in
direct contact with maternal blood, thereby providing
so-called hemochorial exchange for gases, nutrients
and placental hormones. There are also some possible
functional homologies between the tissue components of
the human and mouse placentae, a fortunate circumstance,
because mouse genetics have been able to provide useful,
though limited, inferences to be drawn about human pla-
cental development and pathologies (Cross 2005; Senner
and Hemberger 2010). However, such models and compar-
ative morphological and functional studies can only go so
far and there continues to be profound ignorance about the
early stages of human pregnancy, especially associated with
the events accompanying implantation, when embryonic
losses are high (Macklon et al. 2002) and about the mech-
anisms that underpin the emergence of various mature cell
lineages from the initiating trophectoderm and its descend-
ants. Ethical and legal considerations, in any case, place
Fig. 1 Representation of the human placenta during the process of
uterine invasion. After initial penetration into maternal tissues by cells
derived from blastocyst trophectoderm, which are believed to form a
short-lived syncytium, underlying cytoTBs push through the syncytial
mass and form chorionic villi (CV). Early CV form multilayered
structures that ultimately give rise to anchoring and “floating” (ones
not immediately connected to maternal endometrial tissues) CV. Here,
for simplification, only anchoring villi are shown. a The early stages of
placental development take place in a relatively hypoxic environment
that favors cytoTB proliferation rather than differentiation along the
invasive pathway. Accordingly, this cell population (light green cells)
rapidly increases in number as compared with the embryonic lineages.
CytoTB also differentiate into syncytioTB, which lines the interface
between the placental villous and the intervillous space. This space
ultimately becomes filled with maternal blood. b As development
continues, cytoTBs (dark green cells) invade the uterine wall
and plug the maternal vessels, a process that helps maintain a state of
physiological hypoxia. As indicated by the short black arrows, cytoTBs
migrate farther up arteries than veins. c By 10–12 weeks of human
pregnancy, blood flow to the intervillous space begins. As the endovas-
cular component of cytoTB invasion progresses, the cells migrate along
the lumina of spiral arterioles, replacing the maternal endothelial lining.
CytoTBs are also found in the smooth muscle walls of these vessels. In
normal pregnancy, the process whereby placental cells remodel uterine
arterioles involves the decidual and inner third of the myometrial portions
of these vessels. As a result, the diameter of the arterioles expands to
accommodate the dramatic increase in blood flow that is needed to
support rapid fetal growth later in pregnancy. It is likely that failed
endovascular invasion leads, in some cases, to abortion, whereas an
inability to invade to the appropriate depth is associated with preeclamp-
sia and a subset of pregnancies in which the growth of the fetus is
restricted. The figure is reproduced from Red-Horse et al. (2004)
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curbs on experiments that can be performed on cultured
human conceptuses.
In addition to the difficulties in addressing events of
early pregnancy, there is also little known about the
etiology of placental diseases, such as preeclampsia,
which have their origins early but are manifested in
the third trimester and most often in the last few weeks
of gestation, when fetal demands place considerable
stress on the mother even when she is bearing a normal
placenta (Roberts and Gammill 2005). As has been
pointed out by us (Schulz et al. 2008) and others (Golos
et al. 2006; Douglas et al. 2009; Marchand et al. 2011), there
remains a need for in vitro systems that can mimic early events
in the development of the human placenta better than is
possible with immortalized or cancerous TB cell lines and
primary cultures of placenta, whether collected at term or from
early pregnancy terminations. Importantly, TB stem cells that
might be used to track such early events have yet to be isolated
from the human, despite success in the mouse (Roberts and
Fisher 2011).
As pointed out above, models useful for studying
human TB development are limited. TB isolated from
term placenta (Frank et al. 2001) has been used to
elucidate some aspects of sycytioTB formation (Aplin
et al. 2006) but only primary cells from first trimester
tissue will spontaneously form extravillous trophoblast
(EVT) (Genbacev and Miller 2000). Such material is
not widely available and even the primary cells from
such sources have only a limited capacity to proliferate
and must be repeatedly isolated (Douglas et al. 2009).
However, the recent establishment of continuously proliferat-
ing cell lines from first trimester chorion with the properties of
multipotent cytoTB precursors may remedy this situation
(Genbacev et al. 2011).
Choriocarcinoma cell lines display some properties of
EVT (King et al. 2000; Shiverick et al. 2001). These lines
are easy to maintain and respond to treatments that drive
differentiation and invasion but their behavior is often quite
different from that of the primary TB they are intended to
mimic (Graham et al. 1994; Hohn et al. 1998; Zhang et al.
2002) and their exact place in the TB lineage is unclear.
Recent work based on HLA expression suggests that
JEG3 cells to some extent resemble EVT, while JAr is
more representative of villous TB (Apps et al. 2009).
Some anomalies observed in such cells may also be due
to their tumor cell origins (Khoo et al. 1998a, b; Lee et
al. 2001; Lala et al. 2002). Immortalized cell lines with
EVT properties such as TEV-1 (Feng et al. 2005),
Swan-71 (Fest et al. 2008), TCL1 (Fukushima et al.
2003), SGHPL-4 (Cartwright et al. 1999) and HTR8
(HTR-8/SVneo) (Graham et al. 1993) are also available.
The latter cell line, in particular, contains a subpopula-
tion of cells with multi-lineage differentiation capability
(Takao et al. 2010) but it is unclear whether these
represent TB stem cells or even their early progeny.
Clearly, models are required for studying TB emergence
and differentiation, which are easily maintained in cul-
ture, yet closely represent normal TB in its early com-
mitment stages.
Two such model systems have surfaced during the
past decade to study human TB differentiation from
pluripotent precursor cells. The first (“TB from embryoid
bodies”), which will be reviewed only briefly, has been
to isolate TB from embryoid bodies. The second (“TB
derivation through exposure of “primed” pluripotent stem
cells to BMP4”), which is the main focus of this paper,
is the direct conversion of pluripotent stem cells of
human origin embryonic stem cells (hESC) and induced
pluripotent stem cells (hiPSC) to cells of the TB lineage
by blocking the signaling systems essential for maintain-
ing pluripotency and exploiting instead a competing
SMAD1/5/8 pathway through addition of bone morpho-
genetic protein-4 (BMP4) or related growth factors to the
culture medium.
TB from embryoid bodies
The derivation of TB from embryoid bodies assembled from
hESC was described by Gerami-Naini et al. ( 2004) and has
been reviewed several times recently (Golos et al. 2006, 2010;
Douglas et al. 2009). The approach has been to disperse the
cells into clumps, which are then cultured under conditions
where they cannot re-adhere. The aggregates are then put
under conditions that promote differentiation, usually by
replacing the standard ESC culture medium containing FGF2
with one supplemented with fetal bovine serum (FBS). After
about a week of culture, the embryoid bodies are allowed to
attach to a substratum, usually Matrigel, upon which they form
outgrowths enriched in TB. The value of this system is that, to
some extent, it appears to mimic the early spatial disposition
events of TB formation in the conceptus, with TB enclosing
other lineages in a three-dimensional format. It is also possible
to reconstitute embryoid bodies with a mixture of cell types,
thereby allowing tissue interactions on TB properties to be
examined (Giakoumopoulos et al. 2010). The embryoid bodies
produce copious amounts of hCG and display a range of
diagnostic TB markers. Component cells with a TB phenotype
also exhibit migratory properties (Harun et al. 2006; Golos et
al. 2010; Udayashankar et al. 2010). Finally, individual cell
lines have been derived from such outgrowths by using hCG
production as a marker for selection (Harun et al. 2006) but the
claim that such cells are stem cells (Harun et al. 2006; Frost et
al. 2010) may be overstated in view of the fact that high hCG
production is a feature of differentiated TB and a TB stem cell
phenotype remains unproven.
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TB derivation through exposure of “primed”
pluripotent stem cells to BMP4
Introduction
The experimental system first described by Thomson’s group
(Xu et al. 2002; Xu 2006) and later by us (Das et al. 2007;
Schulz et al. 2008) and others (Besser 2004; Gerami-Naini et
al. 2004; Golos et al. 2006; Zhang et al. 2007; Wu et al. 2008;
Douglas et al. 2009; Erb et al. 2011; Marchand et al. 2011), in
which hESC are driven towards TB in response to the growth
factor BMP4, is particularly attractive in that it allows the
“birth” of TB to be followed from pluripotent progenitors
and the subsequent differentiation of these early TB to be
followed along specific sub-lineages. This phenomenon,
which is observed with primed type ESC, such as those
derived from human blastocysts but not in naïve type ESC
represented, for example, by mouse ESC (see “Naïve versus
“primed”/epiblast-type embryonic stem cells”), can probably
be attributed in part to the underlying differences in pluripo-
tency that distinguish the two cell types. In the review that
follows, we briefly contrast the naïve and primed pluripotency
states and the potential value of using iPSC of the primed type
rather than ESC as the TB progenitor cells for species where
ESC are unavailable (see “Induced pluripotent stem cells
(iPSC) as an alternative to ESC”). Emphasis is given to
delineate the underpinnings of the BMP4/hESC model sys-
tem, including some of its weaknesses and strengths (see “The
opposing roles of FGF2 and BMP4 in directing TB lineage
formation”). We also describe the likely involvement of O2 in
the differentiation process (in “Oxygen acceleration of TB
differentiation”) and the possibility of employing pharmaco-
logical agents rather than just BMP4 to provide directionality
to the emergence of TB sub-lineages (in “Drug-driven differ-
entiation of hESC to TB”). Finally, we discuss recent chal-
lenges to the model and its legitimacy as an experimental
paradigm for TB investigation (in “Do hESC offer a means
of generating human TB stem cells?” and “Is TB derived from
BMP4-treated hESC and iPSC a mesoderm derivative?”)
Naïve versus “primed”/epiblast-type embryonic stem cells
Human ESC, despite being derived from the ICM of blas-
tocysts, show little obvious resemblance to mouse ESC,
which were first generated almost 20 years earlier, also from
blastocysts. Human ESC colonies have a flattened rather
than raised morphology and require a different set of growth
factors than their mouse counterparts, which depend upon
LIF/STAT3 signaling for maintenance of their pluripotency
(Hall et al. 2009). These and other differences have been
reviewed in several publications and will not be covered in
detail here. More recently, a different kind of mouse ESC
was derived from the epiblast of gastrulation stage mouse
embryos (Brons et al. 2007; Tesar et al. 2007). These cells
shared striking similarities to hESC in colony morphology,
requirement for activin A and FGF2 and lack of dependence
on LIF and have been called “primed” or epiblast stem cells
(EpiSC) to distinguish them from the “naïve”, ICM-derived
ESC (Nichols and Smith 2009; Hanna et al. 2010b). The
mouse EpiSC also differentiate in response to BMP4 in a
manner similar to hESC (Brons et al. 2007; Tesar et al.
2007; Vallier et al. 2009; Bernardo et al. 2011). Although
EpiSC and naïve ESC can be inter-converted by genetic
manipulation and even by selection through altered culture
conditions (Bao et al. 2009; Hanna et al. 2010a; Xu et al.
2010), it is clear that the two stemness states are supported
by different signaling networks and react differently to
directing stimuli, although in reality the naïve and primed
states may be in an equilibrium whose dynamic balance can
be shifted experimentally (Greber et al. 2010). For example,
naïve mESC are prone to TB differentiation in response to
BMP4 when they are grown on a laminin or fibronectin
surface, possibly because they begin to acquire a primed
phenotype on these matrices prior to their differentiation to
TB (Hayashi et al. 2010). Considering that naïve ESC are
derived from cells that only recently diverged from trophec-
toderm, it is curious that they resist ready transformation to
TB, whereas EpiSC, whose origins are well-separated from
the TB lineage readily make the lineage switch. This
conundrum is discussed further in “Is TB derived from
BMP4-treated hESC and iPSC a mesoderm derivative?”
where we consider whether or not EpiSC can be used to
provide a source of “true” TB and TB stem cells in light of a
recent publication criticizing this model (Bernardo et al.
2011).
Induced pluripotent stem cells (iPSC) as an alternative
to ESC
Reprogramming somatic cells, first with retroviral vectors
carrying transcription factor genes characteristic of the stem-
ness state (Takahashi and Yamanaka 2006) and later by
other means (Hochedlinger and Plath 2009; Cox and
Rizzino 2010), have demonstrated that the pluripotent pheno-
type can be readily recreated in the laboratory. How similar
these cells are to ESC and whether or not they carry an
epigenetic memory of their origins continues to be argued
(Bock et al. 2011). Nevertheless, iPSC colonies fall into two
general phenotypes, ones that resemble naïve, LIF-dependent
ESC, e.g. frommouse and those that are clearly of the epiblast
type as generated from human and pig somatic cells (Telugu et
al. 2011). As far as can be discerned, the epiblast types of
iPSC, whether from human or pig, respond to BMP4 in a
similar manner as their true EpiSC counterparts and readily
form TB (Alberio et al. 2010; Wolfrum et al. 2011). Such cells
clearly provide an alternative to using hESC and additionally
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should allow the transition to TB from iPSC to be compared
across species that possess contrasting kinds of specialized
placental cell.
The opposing roles of FGF2 and BMP4 in directing TB
lineage formation
In the initial study of Xu et al. (2002), in which BMP4 and
several related growth factors, for example BMP2 and
BMP7, were used to drive differentiation of several hESC
lines, including the now well-studied H1, H7 and H9 cells,
to TB, a number of important observations were made. First,
differentiation was visible as a progressive gain of epithelial
morphology of cells within the colony, a transition that
advanced from the periphery towards the center. Second,
the rate of colony transformation in terms of acquisition of
epithelial phenotype was dose-dependent in relation to the
concentration of BMP provided in the medium. At 100 ng,
BMP4/ml progression was rapid, whereas at 10 and 1 ng/ml
it was significantly slower. Importantly, although not com-
mented upon in detail in the 2002 publication, the absence
of FGF2 appeared to enhance BMP4-driven differentiation,
an observation later confirmed by number of other investi-
gators (Das et al. 2007; Marchand et al. 2011; Yu et al.
2011). Third, even though BMP2, BMP7 and GDF5 could
mimic the effects of BMP4, other members of the TGFB
family, including TGFB itself and activin A were ineffec-
tive, in retrospect, a not unsurprising observation, as these
latter factors, along with FGF2, can help maintain the plu-
ripotent state of hESC. And fourth, there was a progressive
up-regulation of gene markers, including ones encoding
several transcription factors that are candidate markers for
the TB lineage. In addition, many markers of “mature”
syncytial TB, such as CGA and CGB, were up-regulated
quite late in the process, usually after several days, suggest-
ing that the transformation to TB proceeded through a
number of intermediate steps before functionally mature
cells appeared. Nonetheless, there was also evidence that
the process, at least in its initial stages, was not exclusively
to TB, as close examination of the microarray data at early
time points reveals there was expression of primitive (yolk
sac) and definitive endodermal gene markers, such as AFP
(alpha-fetoprotein), RBP4 (retinol binding protein 4) and
FGG (fibrinogen-γ).
Experiments performed in several laboratories, including
our own (Das et al. 2007; Schulz et al. 2008), subsequently
confirmed most of the above observations. In our case, we
initially concentrated on how FGF2 and oxygen tension
played into the differentiation process. Using a single, rela-
tively low BMP4 concentration (10 ng/ml) and a 2 × 2
factorial design, we compared differentiation of H1 and
H9 cells in the presence and absence of 4 ng/ml FGF2 and
under contrasting gas atmospheres of 20% and 4% O2. The
results were quite clear. FGF2 slowed the differentiation
process under the two gas atmospheres both in terms of
morphological transformation of the cells and the produc-
tion of the hormones hCG and progesterone (P4). Indeed, in
the presence of FGF2, P4 release into the medium over a 5-
day time course was almost completely suppressed under
either O2 condition (Das et al. 2007). It was also evident that
late differentiation events were additionally slowed under
low O2 conditions but otherwise appeared to progress not
very differently than under high (20%) O2. Accordingly,
FGF2 was omitted from the culture medium in all our
subsequent experiments when BMP4 was employed to drive
TB differentiation (Das et al. 2007; Schulz et al. 2008).
The complicating nature of the presence of FGF2 on
BMP4 differentiation has been observed by others. For
example, the tendency of hESC to differentiate spontane-
ously during routine culture could at least in part be attrib-
uted to the presence of BMPs that antagonized the ability of
FGF2 to maintain the pluripotent state, suggesting that the
signaling pathways activated by the two growth factors
interacted in some manner (Wang et al. 2005; Xu et al.
2005; Ludwig et al. 2006; Lin et al. 2010). Subsequently,
Yu et al. (2011) noted that, in a defined culture medium
developed specifically for maintaining hESC in a pluripo-
tent state and containing relatively high concentrations of
FGF2 (mTeSR medium) (Ludwig et al. 2006), FGF2 sig-
naling through the MEK/ERK signaling pathway negated
the effects of BMP4 in promoting TB differentiation. In-
stead, the combination of the two growth factors resulted in
prolonged NANOG expression and up-regulation of primi-
tive streak gene markers, especially T (brachyury), as well
as endoderm and mesoderm marker genes. Only when
FGF2 in the medium was reduced in concentration or omit-
ted completely was BMP4 able to induce TB formation
efficiently and only in the absence of BMP4 was pluripo-
tency maintained. More recently, Bernardo et al. (2011)
have argued that the role of BMP4 is to block endoderm
formation and permit differentiation to mesoderm and that
the cells expressing TB markers are not “true” TB at all
but a derivative of mesoderm arising as an artifact of in
vitro culture. Indeed, these workers insist that hESC do
not have any capacity to generate TB “simply by addition
of BMP4 to their growth medium in either the presence or
absence of FGF2”. We attempt to refute this argument
later in this paper.
The complex nature of the BMP4/FGF2 relationship is also
emphasized when the expression patterns of their genes are
analyzed. H1 hESC maintained on a medium conditioned by
MEF, which likely contains BMP4 (Wang et al. 2005; Xu et
al. 2005; Lin et al. 2010; Yu et al. 2011), express both FGF2,
BMP4 and INHBA (gene encoding activin A subunits)
(Fig. 2), which may contribute to the unstable phenotype of
the cells, i.e., spontaneous differentiation (Ezashi et al. 2005;
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Westfall et al. 2008). Upon exposure to added BMP4, expres-
sion of FGF2 (Fig. 2) and genes encoding its regulators,
POU5F1 and SOX2 (Schulz et al. 2008), fall, while transcript
concentrations for FGFR2, whose two main splice variant
forms bind a variety of FGF ligands, including FGF2 and
FGF4 (Katoh and Katoh 2009), remain relatively unchanged
(Fig. 2). Additionally, there is minor up-regulation of FGF4, a
growth factor essential for maintaining the self-renewal of TB
stem cells in the mouse (Tanaka et al. 1998) and a product of
the pluripotent ICM and epiblast of mouse embryos, where it
probably acts locally to promote TB proliferation. The expres-
sion of the genes encoding BMP4 and its major cognate
Fig. 2 Relative transcript concentrations of several genes for growth
factors and their cognate receptors whose expression could influence
differentiation events in BMP4-treated H1 cells. Data (GEO
GSE10469) were obtained by microarray over time and in response
to O2. Values were normalized to the median intensity of the array. H1
hESC were supplemented with BMP4 (10 ng/ml) under either 4%
(blue) or 20% (red) O2 conditions. RNA isolated at 0, 3, 12, 24, 72
and 120 h (Schulz et al. 2008). These data were obtained on Agilent
Whole Human Genome Oligo microarrays. The value represents a
normalized expression (1.0 being the signal at the 50th percentile).
For details of methods, see Schulz et al. (2008). Values shown are for a
(FGF2), b (FGF4), c (FGFR2), d (BMP4), e (BMP7), f [BMPR1A
(ALK3)], g (INHBA) (gene encoding activin A subunits), h [ACVR1
(ALK2)] and i [TGFBR1 (ALK5)]. Note that the cells may continue to
have the potential to respond to endogenously produced FGF2 and
activin A even when exogenous sources are absent
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receptor, BMPR1A (ALK3), rises after application of BMP4 to
H1 cells (Fig. 2), thereby ensuring a positive feed-back loop.
Transcripts for BMP7 are also detectable in the H1 cells both
before and after BMP4 exposure, so that its protein product
may reinforce the conditions promoting ESC differentiation. It
is also important to note that genes encoding activin A
(INHBA) and its cognate receptors are also maintained in the
H1 cells after BMP4 exposure (Fig. 2), raising the possibility
for conflict between the pathways driving differentiation with
those that maintain pluripotency.
The fact that added FGF2 opposes the directionality of
BMP4-driven differentiation of hESC towards TB has
meant that most researchers seeking to follow TB emer-
gence no longer include FGF2 in the medium after BMP4
is added. This practice has the additional advantage of
allowing the use of lower BMP4 concentrations to provide
relatively rapid transformation of the colonies to TB and a
significant cost savings to the investigator. In addition,
exclusion of FGF2 avoids the diversion of the hESC to
lineages other than TB quite efficiently. For example, micro-
array analysis of H1 cells after 3, 12, 24, 72 and 120 h
treatment with 10 ng/ml BMP4 (GEO GSE10469) revealed
immediate up-regulation of transcription factors associated
with TB emergence, e.g. CDX2, ID2, LEF, EBF3, HAND1,
DLX3 and 5, MSX2, GATA2 and 3, FOXF2, with no evi-
dence for up-regulation of expression of lineage markers for
mesoderm (WNT3A, BRACHYURY/T), endoderm (HOXB1,
DPF3) and ectoderm (PAX6, ZIC1) over the time course of
treatment (GEO GSE10469). Thus, predominantly TB
emerges when hESC are treated only with BMP4. These
observations were subsequently confirmed by Marchand
et al. (2011).
Oxygen acceleration of TB differentiation
The human conceptus, like that of other species, initially
develops under conditions that are approaching hypoxic and
certainly low in O2. As ESC are derived from the ICM or
epiblast of such conceptuses, we hypothesized that such
cells could be grown successfully under such hypoxic con-
ditions. This hypothesis proved to be correct. H1 cells, for
example, divided just as quickly under 3 and 5% O2 as they
did under 20% O2 and were only slowed slightly at 1% O2
(Ezashi et al. 2005). On the other hand, TB cells, which
initially surround the inner pluripotent cells, seem likely to
be exposed to somewhat higher O2 conditions than inner
cells from the time the lineages separate and may mop up
much of the available O2. Moreover, towards the end of the
first trimester of human pregnancies, the intervillous space
becomes fully perfused with oxygenated maternal blood
(Burton et al. 2002). Therefore, TB cells on or near the
surface of the fetal villi will face O2-rich conditions. Similarly,
the extravillous TB component of the placenta invading into
the uterine wall will also be exposed to increasingly higher
O2 tensions as it approaches maternal arterioles. Such con-
ditions reduce cellular proliferation and favor differentiation
of cytoTBs (Huppertz et al. 2009). Thus, it seemed reason-
able to include O2 as a variable in studies that employ the
BMP4/hESC model.
As described earlier, differentiation is accelerated under a
high O2 atmosphere in the sense that the colonies make the
transition to an epithelial morphology more rapidly than at
low O2 (Das et al. 2007). Another longer term morpholog-
ical feature of BMP-treated hESC colonies is the formation
of syncytial TB, a cell type that occupies extensive areas of
the colonies under high O2 atmosphere, appearing 72–120 h
after BMP4 exposure but more slowly in colonies main-
tained under 4% O2. Gene markers of syncytioTB reflect
these differences in that their appearance is delayed by
approximately 24 h (Schulz et al. 2008). Clearly, O2 has a
profound influence on the rate at which BMP4 drives hESC
to terminally differentiated TB.
The initial, BMP4-controlled, up-regulation of several
transcription factors believed to be associated with TB stem
cells and TB emergence, discussed in “The opposing roles
of FGF2 and BMP4 in directing TB lineage formation”, is
also oxygen sensitive. Such O2 response differences are
particularly obvious for CDX2 and EOMES (data that have
been confirmed by quantitative RT-PCR; not shown), for
example, whereas others, e.g. ETS2 and GATA3, seem less
influenced by the gas atmosphere (Fig. 3), the basis of these
differences in relation to O2 tension is unclear but are
presumed related to the relative instability of the HIF1A
transcription factor as O2 tensions rise (Semenza 2007).
The data are also consistent with previous observations from
our laboratory that under 20% O2 the cells are more poised
to differentiate than when they are under the low O2 con-
ditions (Westfall et al. 2008). Key controllers of these events
may be LEFTY1 and 2, whose genes display a 2- to 3-fold
higher expression under 4% as compared to 20% O2 in
hESC and are rapidly down-regulated either by addition of
BMP4 (Schulz et al. 2008) or by inhibiting the activin A-
linked kinases ACVR1B, TGFBR1 and ACVR1C with the
drug SB431542 (Besser 2004). LEFTY proteins, which are
members of the TGFB superfamily, are regulated in plurip-
otent stem cells by a combination of SOX2 and POU5F1
(Boyer et al. 2005). LEFTY2, in particular, appears to
antagonize differentiation initiated by NODAL signaling
by blocking the formation of an active NODAL/activin A
receptor complex (Schier and Shen 2000; Sakuma et al.
2002; Schier 2003). NODAL is a required factor for mouse
TB stem cell renewal and, as a product of mitotically inac-
tivated mouse embryonic fibroblasts, has likely been present
in most culture media used to support hESC until the recent
availability of defined media (Roberts and Fisher 2011).
Again, such data support the idea that the pluripotent
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networks supporting stemness are relatively unstable and are
further compromised as O2 tensions rise.
Drug-driven differentiation of hESC to TB
Self-renewal and conservation of pluripotency in hESC
requires either activin A or related factors (Beattie et al.
2005; James et al. 2005; Vallier et al. 2005; Chng et al.
2011) and FGF2 (Vallier et al. 2005; Wang et al. 2005). As
pointed out above, the former binds to the ACVR1B,
TGFBR1 and ACVR1C receptors, whose ability to initiate
downstream signaling events, namely activation of the
transcriptional modulators SMAD2 and SMAD3, can be
blocked by the kinase inhibitor 4-[4-(1,3-benzodioxol-5-
yl)-5-(2-pyridinyl)-1H-imidazol-2-yl]benzamide, better
known as SB431542 (Laping et al. 2002). Hence, SB431542
has become widely used to block TGFB/activin/NODAL
signaling in a variety of cell types. One outcome of such
inhibition of activin A signaling in hESC is to interfere with
the transcription of key “stemness” genes, such as NANOG
(Xu et al. 2008; Vallier et al. 2009) and LEFTY1 and 2 (Besser
2004) and consequently to impede the signaling network that
sustains hESC self-renewal. As a consequence, SB431542
can be used in conjunction with BMP4 to enhance TB emer-
gence from hESC (Wu et al. 2008; Erb et al. 2011) and
provides a cheaper alternative to using natural polypeptide
inhibitors such as follistatin (Vallier et al. 2005; Saha et al.
2008). More specific and more potent inhibitors of activin A
signaling, such as A83-01 (Tojo et al. 2005; Garamszegi and
Garamszegi 2011), may provide improved tools for directing
hESC to TB (see ‘‘Is TB derived from BMP4-treated hESC
and iPSC a mesoderm derivative?”).
FGF2 is a routine component of both complex and de-
fined media used to culture hESC but exactly how this
growth factor, which is active only as a complex with
heparan sulfate, enhances self-renewal, is still not complete-
ly understood, in large part, because of the complexities that
arise in studying the various spliced forms of FGF receptors,
which differ from each other in ligand-binding affinities,
tissue distribution and differential coupling to distinct intra-
cellular signaling pathways (Eswarakumar et al. 2005).
What is clear is that when FGF2 binds to one or more of
its cognate receptors, each of which possess a tyrosine
kinase domain within their intracellular domains, there is a
Fig. 3 Relative transcript concentrations of genes encoding transcription
factors that have been implicated in TB lineage emergence (Roberts and
Fisher 2011). Values are shown for a (CDX2), b (EOMES), c (ETS2), d
(GATA3), e (TFAP2C) and f (ELF5). The data were obtained as described
in the legend to Fig. 2 from cells maintained under either 4% (blue) or
20% (red) O2 conditions. RNAwas isolated at 0, 3, 12, 24, 72 and 120 h
after BMP4 exposure (GEO GSE10469)
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cascade of phosphorylation events involving several signal-
ing pathways (Ding et al. 2011; Zoumaro-Djayoon et al.
2011). The one that appears to be most relevant to the
maintenance of stem cell renewal and pluripotency involves
RAS/RAF/MEK1/2 and leads to activation of ERK1/2
(Kang et al. 2005; Li et al. 2007) and, as with activin A
signaling, maintenance of NANOG levels (Yu et al. 2011).
The availability of a wide range of inhibitors, with varying
affinities for the protein kinases components of FGF recep-
tors and their downstream targets (Katoh and Katoh 2009)
provides additional potential tools for directing TB differ-
entiation from hESC. For example, PD173074 has already
been employed to counteract the tendency of FGF2 to direct
differentiation of hESC to endoderm rather than TB in
presence of BMP4 (Yu et al. 2011). Complete blockade of
the FGF2 and activin A response pathways in hESC, will
undoubtedly enhance our ability to guide hESC and iPSC to
TB more uniformly (see “Is TB derived from BMP4-treated
hESC and iPSC a mesoderm derivative?”).
Pharmacological approaches to directing the fate of stem
cells along particular lineages has major advantages to the
investigator, not the least of which is the stability and
consistency of such reagents relative to polypeptides, such
as BMP4, which we have noted to exhibit disconcerting
differences in potencies from lot-to-lot and between differ-
ent suppliers. Indeed, some of the inconsistencies observed
between investigators in BMP/hESC experiments may be
due to differences in BMP4 quality, density and properties
of the feeder cultures providing supporting growth factors
and the size and density of the hESC colonies after they are
sub-cultured. Combinations of FGFR and activin A receptor
inhibitors in concert with defined culture media and careful
quality control over passaging conditions and the progres-
sion of differentiation across the colonies are likely to pro-
vide a simpler and more uniform approach to examining TB
emergence from hESC.
Do hESC offer a means of generating human TB stem cells?
Mouse TB stem cells were first established from outgrowths
of trophectoderm and explants of extra-embryonic ectoderm
dissected from the base of the ectoplacental cone bordering
epiblast over 13 years ago (Tanaka et al. 1998), although it
is not completely clear whether the two types of TB stem
cell so generated are equivalent. Similar approaches had not
yielded comparable types of cells from a primate species
until they were generated from Rhesus monkey blastocysts
(Vandevoort et al. 2007) but comparable human cells have
not been described from blastocyst outgrowths (Genbacev et
al. 2011). Although undoubtedly TB, the monkey lines
warrant additional characterization, as they display a num-
ber of atypical markers and growth features that sets them
apart from mouse TB stem cells (Roberts and Fisher 2011).
Although clusters of dividing cells are present at the base
and tips of cytoTB columns in first trimester placental villi
that carry markers, such as ELF5 and CDX2, similar to
those found on cultured mouse TB stem cells (Hemberger
et al. 2010), such cells have not been isolated and charac-
terized further. The TB-like cells recently isolated from
chorionic membranes may, however, be bona fide candi-
dates as TB progenitor cells, even though they again differ
in many respects from mouse TB stem cells (Genbacev et al.
2011). Early passage cells were initially positive for
POU5F1 and expressed a number of TB markers, including
EOMES, GATA3 and GCM1 and can be differentiated into
cell types that express hCG and HLAG. On the other hand,
the cell lines selected from embryoid bodies on the basis of
CGB expression by Harun et al. (2006) seem unlikely to
represent TB stem cells, because CGB and its partner CGA
are products primarily of syncytioTB and not cytoTB. These
genes are not significantly expressed in colonies of BMP4-
treated hESC until at least 3 days after initiation of differ-
entiation (Schulz et al. 2008).
BMP4-treated hESC in the early stages of differentiation
may provide an opportunity to generate human TB stem cell
lines, although there is no certainty that self-renewing multi-
potent cells exist in the colonies. Moreover, even if they are
present, the technical challenges of isolating and propagat-
ing the cells will remain. Nevertheless, after BMP4 expo-
sure genes for several transcription factors implicated in
establishing mouse TB stem cell self-renewal and multi-
potency, including CDX2, EOMES, TFAP2C and GATA3,
are up-regulated within 3 h, while the mRNA for others,
including ELF5, ETS2 and TEAD4, which are also
expressed in undifferentiated hESC, remain expressed as
the transition proceeds (Fig. 3; and unpublished data avail-
able through GEO GSE10469). Such changes occur before
KRT7, the characteristic cytokeratin of TB, is expressed and
several days before CGA and CGB can be detected (Schulz
et al. 2008). The view that the “predominant cell type that
emerges from the hESC to TB transdifferentiation” is syn-
cytioTB (Hemberger et al. 2010) is simply a misconception.
Even after day 5, syncytioTB is found only at the periphery
of the colonies (Das et al. 2007), at a time when most have
converted completely to a KRT7-positive phenotype. The
time to seek TB stem cells would seem to be in the early,
rather than the late, phase of the trans-differentiation process
and before the specialized tissue types have appeared.
ELF5 expression in hESC is of particular interest. In the
mouse, ELF5 has been proposed to be a “lineage gatekeeper”
controlling the transition of pluripotent progenitor cells, where
CpG islands within the promoter of the gene are hypermethy-
lated and inactive, into the TB lineage where the promoter is
hypomethyated and active (Ng et al. 2008). Even though
Hemberger et al. (2010) have reported that the ELF5 variant
(ELF2b) expressed in proliferating human TB and TB cell
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lines is hypomethylated in its promoter and hence active, it
was hypermethylated and inferred as silent in several human
ESC and iPSC lines. Nonetheless, although the gene is
expressed in the H1 and H9 lines used in our laboratory, it is
not perceptibly up-regulated after BMP4 treatment, as is one
of its presumed downstream targets, EOMES. By contrast,
CDX2 is relatively silent in the pluripotent cells but is up-
regulated within 3 h after BMP4 exposure (Fig. 3). Clearly, the
epigenetic switch postulated to govern TB emergence and to
control ELF5-driven expression of CDX2 and EOMES may
be more complicated in the BMP4/hESC system than envis-
aged in the model proposed by Hemberger et al. (Ng et al.
2008; Roper and Hemberger 2009).
Is TB derived from BMP4-treated hESC and iPSC
a mesoderm derivative?
As mentioned earlier, Bernardo et al. (2011) consider that
BMP4 treatment of hESC in absence of FGF2 and activin A
does not generate TB at all but instead gives rise solely to
mesoderm derivatives. The evidence for this is based primarily
on the following findings.
First, both BMP4 and the activin A signaling inhibitor
SB431542 appeared to up-regulate the brachyury gene
(T), a transcription factor that during embryo develop-
ment is first expressed in mesoendoderm, the immediate
precursor of mesoderm and endoderm, around the time
of blastulation (Jones et al. 1991; Winnier et al. 1995).
However, close examination of the immunoblots shown
in fig. 1B of the paper by Bernardo et al. (2011) indi-
cates little or no effect of BMP4 on brachyury protein
concentrations in H9 cells when compared to untreated
control cells. Moreover, our microarray data also indicate
that the T gene is not immediately responsive to BMP4
(Fig. 4) and that its transcripts are present in initiating
H1 cells even before their exposure to BMP4. This
expression of T in hESC and in the presumed TB cells
generated by BMP-treatment of hESC is not surprising in
view of the fact that brachyury protein is expressed, as
assessed by western blotting, both in pluripotent terato-
carcinoma cells and in at least two TB cell lines, includ-
ing JAr (Gokhale et al. 2000). Clearly, this marker may
not be a faithful indicator of emerging mesodermal dif-
ferentiation. One final point with regard to brachyury is
Fig. 4 Relative transcript
concentrations of genes
encoding mesoderm-associated
markers: a (T), b (KDR),
c (VCAM1) and d (TBX4)
(Bernardo et al. 2011). The data
were obtained as described in
the legend to Fig. 2 from cells
maintained under either 4%
(blue) or 20% (red) O2 condi-
tions. RNAwas isolated at 0, 3,
12, 24, 72 and 120 h after
BMP4 exposure (GEO
GSE10469)
818 Cell Tissue Res (2012) 349:809–824
worth noting. When Bernardo et al. (2011) up-regulated
T and consequently mesoderm specification by exposing H9
cells to BMP4 in presence of FGF2, this response was com-
pletely abolished when endogenous FGF signaling was
inhibited with the inclusion of FGFR or ERK signaling path-
way inhibitors (fig. 1C in Bernardo et al. 2011) (Yu et al.
2011). These outcomes are not consistent with an ability of
BMP4 alone to regulate T. Thus, it would seem essential to
eliminate endogenous as well as exogenous FGF signaling in
hESC to prevent any residual mesoderm specification occur-
ring in response to BMP4. Accordingly, a useful approach to
ensuring that only TB emerges in response to BMP4 will be to
block both activin A and FGF signaling simultaneously by
including either SB431542 or a more specific ALK inhibitor,
such as A83-01 (see “Drug-driven differentiation of hESC to
TB”) (Fig. 5).
Fig. 5 The opposing roles of FGF2 and BMP4 in directing TB
formation from epiblast type ES cells and iPS cells and the need to
exclude FGF2 from the growth medium to minimize the co-induction
of mesoderm and endoderm. Also indicated are the potential values of
including low molecular weight pharmaceutical agents that block acti-
vin A (INHBA) and FGF2 signaling to support BMP4-directed differ-
entiation to TB. Whereas FGF2 and conditioned medium (CM) from
mouse embryonic fibroblasts, which contains activin A and other
growth factors, enable maintenance of the pluripotent state of epiESC
(top left), adding high concentrations of BMP4 leads to TB differenti-
ation and possibly also some endoderm and mesoderm differentiation
(bottom left). We argue that when BMP4 is present with FGF2 the
extent of emergence of TB will depend on the relative concentrations
of the two growth factors. By contrast, a defined medium supple-
mented with BMP4, FGF2 and activin A appears mainly to generate
endoderm (upper right). However, the same defined medium formu-
lated for minimal activin A signaling gives rise predominantly to
mesoderm (lower right). Addition of BMP4 but minimizing FGF2
contribution to signaling either by excluding it from the culture
medium or blocking MEK1/2 signaling, strongly favors TB for-
mation, as does the inhibition of the activin A-mediated SMAD2/3
pathway (triad cluster in center). Blocking signaling through both the
SMAD2/3 and MEK1/2 pathways in the presence of BMP4 will most
likely provide optimal, unidirectional differentiation towards TB
and the HLAG+ /cytoTB and CG+/syncytioTB sublineages (dashed
circle in center)
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Second, according to Bernardo et al. (2011), three genes
with essential roles in embryonic and extra-embryonic en-
doderm, namely KDR (FLK1), VCAM1 and TBX4, were up-
regulated by BMP4 at 36 h in the H9 hESC line. Our data
(Fig. 4), however, indicate that with the possible exception
of KDR/FLK1, a member of the VGF receptor family and
known to be expressed in human EVT (Iacob et al. 2008),
these genes are expressed relatively weakly in H1 hESC,
with very little up-regulation by BMP4 over the initial 3 days
of exposure. In any case, fold up-regulation parameters can
be very misleading when expression in the initiating control
cells hovers close to baseline, e.g., VCAM1 and TBX4.
Third, CDX2, often considered a marker of emerging TB,
was more strongly up-regulated in presence of FGF2 plus
BMP4 than when FGF2 was omitted (fig. 1A in Bernardo et
al. 2011), suggesting that this transcription factor is involved
in mesoderm as well as TB specification. Moreover, when
CDX2 was silenced, there was a corresponding fall in ex-
pression of mesodermal markers. The results are consistent
with CDX2 expression correlating with and possibly play-
ing a role in mesoderm emergence but they certainly do not
rule out its involvement in specification of TB when FGF2
is absent from the medium.
Fourth, the ELF5 gene remained hypermethylated in
BMP4-treated hESC and only a small percentage of the
cells expressed the protein. Since ELF5 promoter hypome-
thylation is a feature of mouse TB stem cell, it is argued that
the BMP-exposed cells could not be TB. However, the
methylation status of the ELF5 promoter in the minority of
the cells that actually expressed ELF5 was not determined
and it seems conceivable that this sub-population might
represent early stage, emerging TB within the colonies.
Fifth, whereas the BMP4-treated hESC expressed surface
class I HLA molecules (for the most part HLA-A and HLA-
B), they did not express the non-polymorphic HLA-G and -
C molecules (fig. 4C in Bernardo et al. 2011). The absence
of HLA-G is particularly puzzling, as, in our hands, H1
colonies treated with 10 ng/mlBMP4 and interrogated by
use of a well-defined monoclonal antibody (McMaster et al.
1995) as a detection agent exhibited strong signals for both
surface and internal HLA-G (Das et al. 2007). Moreover,
such colonies also express HLA-G transcripts (GEO
GSE10469), an outcome independently described by others
(Marchand et al. 2011). It is difficult to reconcile these
contrasting data and interpretations until the experiments
are repeated with additional cell lines, events followed care-
fully over time after BMP4 exposure and consideration
being given to the fact that markers such as T and KDR/
FLK1, may not be absolute in their specificities.
An essentially theoretical line of reason has also been raised
against the BMP4/hESC model for studying TB differentia-
tion, namely that hESC are generated from the inner cell mass
of expanded blastocysts when an ICM contribution to
trophectoderm is unlikely to occur. In the case of mouse
EpiSC, the lines are created from an even more advanced stage
of development, the late epiblast. This argument is difficult to
counter, although it would be naïve to assume that any of the
pluripotent cells are exact equivalents of their progenitors.
Instead, they may be derived from only a subpopulation within
the tissue of origin or even artifacts of in vitro culture.
A further argument against BMP4 specification of TB is
that mouse embryos, in which both copies of the BMP4 gene
have been inactivated, implant successfully and on time and
only fail in their development at the egg cylinder stage
(Winnier et al. 1995), a phenotype consistent with a role
for BMP4 in gastrulation and mesoderm formation but not
in establishment of TB and implantation. On the other hand,
Winnier et al. (1995) also noted that there was partial rescue
of a significant number of the homozygous mutants, i.e.
some survived to term and beyond, possibly through action
of either “related proteins” or through complementation by
maternal BMP4. In this regard, mRNA for multiple BMP
genes, including those for BMP4, BMP2 and BMP7, are
strongly expressed in decidual tissue on the mesometrial side
of the uterus adjoining implantation sites. BMP7 may be of
particular relevance in this regard. First, like BMP4, BMP7
supports hESC conversion to TB (Xu et al. 2002); second, it
is expressed in uterine epithelium of the mouse (Ozkaynak
et al. 1997) and in the primary decidual zone in contact
with the ectoplacental cone during implantation (Ying and
Zhao 2000). Conceivably, one or more maternal BMP
proteins and possibly BMP7 rather than BMP4, provide
the stimulus for trophectoderm outgrowth and establish-
ment of a rudimentary placenta, both in these mutants and
in wild-type conceptuses.
In our view, the line of reasoning provided by Bernardo et
al. (2011) that TB is not formed when hESC are exposed to
BMP4 is flawed, although we do not quarrel with the possibil-
ity that TB might carry a partial mesoderm identity. Based on
the available evidence, we suggest that, when signaling net-
works supporting pluripotency in epiblast-type ESC or iPSC
(namely the FGF and the activin A signaling axes mediated
through FGF2/ERK and SMAD2/3, respectively) become un-
sustainable and when specification towards extra-embryonic
mesoderm and endoderm are simultaneously blocked, TB
emerges as a major default state to pluripotency (Ezashi et al.
2011; Roberts and Fisher 2011) (Fig. 5). The inclusion of
BMP4 under these conditions is probably necessary both to
accelerate the process and to prevent the acquisition of a
neuronal phenotype (Avery et al. 2010) as an alternative to TB.
Concluding remarks
The weight of evidence indicates that BMP4 can convert
hESC and iPSC unidirectionally to TB, provided that the
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signaling pathways supporting pluripotency or driving en-
doderm and mesoderm specification are rendered inopera-
tive (Fig. 5). The model has the promise to provide a series
of snapshots into the spatial and temporal changes that
accompany initial differentiation from pluripotent cells and
the subsequent formation of sycytialTB and other subline-
ages as they arise from cytoTB precursors. It may also
afford insight into the molecular events that trigger these
developmental transitions. The model should be adaptable
to a three-dimensional format and to studying the interaction
between TB and other cell types, including blood vessels.
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